Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Neonicotinoid pesticide reduces ovary development in bumblebee queens
Bumblebee
The study looked at the feeding behaviour and ovary development of four species of bumblebee queen.

Thiamethoxam also found to affect feeding behaviour

Wild bumblebee queens are less able to develop their ovaries when exposed to a common neonicotinoid pesticide, new research has found.

Writing in the journal Proceedings of the Royal Society B, researchers describe an investigation into the impact of exposure to field-realistic levels of thiamethoxam.

Conducted by a team at the Royal Holloway University of London, the study looked at the feeding behaviour and ovary development of four species of bumblebee queen.

“We consistently found that neonicotinoid exposure, at levels mimicking exposure that queens could experience in agricultural landscapes, resulted in reduced ovary development in queens of all four species we tested,” said lead author Dr Gemma Baron.

“Impacts of neonicotinoid exposure on feeding behaviour were species-specific, with two out of four species eating less artificial nectar when exposed to the pesticide. These impacts are likely to reduce the success of bumblebee queens in the spring, with knock-on effects for bee populations later in the year".

The study is the first of its kind to analyse the impacts of these chemicals across multiple bumblebee species. Previously, scientists have focused on a single bumblebee species and assessed impacts in workers and established colonies.

Thiamethoxam is a synthetic pesticide that is currently under an EU moratorium, together with two other neonicotinoids.

"The EU and other countries are weighing the benefits of using neonicotinoids to protect crops, against real concerns about how such pesticides can cause unintended harm to pollinators and other beneficial insects,” explained co-author Professor Raine.
“This work on wild bumblebee queens adds significantly to the evidence base on which to make such important policy decisions”.

The researchers add that their work provides a ‘major step forward’ in understanding the impacts of neonicotinoids on wild bees.

“Future studies across different species are likely to demonstrate further variation in the impact of neonicotinoids,” they conclude. “Conducting such studies needs to be a priority for scientists and governments”.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.